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Abstract 
Objective 
To assess the separate and combined associations of maternal prepregnancy body mass index 
(BMI) and gestational weight gain with the risks of pregnancy complications and their population 
impact. 
Design 
Individual participant data metaanalysis of 39 cohorts. 
Setting 
Europe, North America, and Oceania. 
Population 
265 270 births. 
Methods 
Information on maternal prepregnancy BMI, gestational weight gain, and pregnancy 
complications was obtained. Multilevel binary logistic regression models were used. 
Main outcome measures 
Gestational hypertension, preeclampsia, gestational diabetes, preterm birth, small and large for 
gestational age at birth. 
Results 
Higher maternal prepregnancy BMI and gestational weight gain were, across their full ranges, 
associated with higher risks of gestational hypertensive disorders, gestational diabetes, and large for 
gestational age at birth. Preterm birth risk was higher at lower and higher BMI and weight gain. 
Compared with normal weight mothers with medium gestational weight gain, obese mothers with 
high gestational weight gain had the highest risk of any pregnancy complication (odds ratio 2.51, 
95% CI 2.31– 2.74). We estimated that 23.9% of any pregnancy complication was attributable to 
maternal overweight/obesity and 31.6% of large for gestational age infants was attributable to 
excessive gestational weight gain. 
Conclusions 
Maternal prepregnancy BMI and gestational weight gain are, across their full ranges, associated 
with risks of pregnancy complications. Obese mothers with high gestational weight gain are at the 
highest risk of pregnancy complications. Promoting a healthy prepregnancy BMI and gestational 
weight gain may reduce the burden of pregnancy complications and ultimately the risk of maternal 
and neonatal morbidity. 
Tweetable abstract 
Promoting a healthy body mass index and gestational weight gain might reduce the population 
burden of pregnancy complications. 
Introduction 
Obesity among women of reproductive age is increasing in prevalence worldwide.1 A 
metaanalysis of published data of 38 cohorts reported that not only maternal obesity but also 
modest increases in maternal body mass index (BMI) were associated with an increased risk of fetal 
and infant death. For women with a BMI of 30 kg/m2, absolute risks per 10 000 pregnancies were 
102 and 43 fetal and infant deaths, respectively.2 Maternal overweight and obesity are also 
associated with increased risks of more common pregnancy complications, such as gestational 
hypertensive disorders, gestational diabetes, preterm birth, and large for gestational age at birth.3-5 
Next to maternal prepregnancy BMI, excessive gestational weight gain, defined by the US 
Institute of Medicine (IOM) criteria, is associated with increased risks of pregnancy 
complications.6-9 However, most previous studies have lacked power for a robust assessment of 
whether differences in risk are also present for modest changes in maternal prepregnancy BMI 
and gestational weight gain and by severity of obesity. Although the associations of maternal 
obesity and excessive weight gain with pregnancy complications have been extensively studied, less 
is known about the population disease burden attributable to these conditions.10-12 Gaining insight 
into the populationattributable risks will allow the development of future population preventive 
strategies designed to reduce the risks of common pregnancy complications. Furthermore, a 
metaanalysis of individual participant data (IPD) on this topic, in contrast to the previously 
performed metaanalyses of published results,4, 9 allows more powerful and flexible analyses, 
better harmonisation of the data, and consistent adjustment for potential confounders, and leads to a 
reduced risk of publication bias.  
Therefore, we conducted a metaanalysis of IPD among 265 270 singleton births from 39 
American, European, and Oceania pregnancy and birth cohorts to assess the associations of 
maternal prepregnancy BMI and gestational weight gain with the risks of gestational hypertension, 
preeclampsia, gestational diabetes, preterm birth, and small and large for gestational age at birth, 
and to assess their population impact. 
Methods 
Inclusion criteria and participating cohorts 
We used data from an existing international collaboration on maternal obesity and childhood 
outcomes within the LifeCycle Project (www.lifecycle-project.eu). Pregnancy and birth cohort 
studies were eligible if they included mothers with singleton liveborn children born from 1989 
onwards, had information available on maternal pre or earlypregnancy BMI and at least one 
offspring measurement (birthweight or childhood BMI) and were approved by their local 
institutional review boards. We invited 50 cohorts from Europe, North America, and Oceania 
selected from existing collaborations on childhood health (EarlyNutrition Project, CHICOS Project, 
www.birthcohorts.net assessed until July 2014), of which 39 agreed to participate, providing data of 
277 042 singleton births. Of those, information on maternal pre or earlypregnancy BMI and at 
least one pregnancy complication was available for 265 270 singleton births (flowchart in 
Supporting Information Figure S1). Anonymised data sets were stored on a single central secured 
data server with access for the main analysts (S.S., E.V.). A description of the eligibility criteria, 
and the references of the study design and profile papers of each included cohort are given in 
Supporting Information Table S1. Participants were not involved in the development of the study.  
Maternal anthropometrics 
Maternal anthropometrics were measured, derived from clinical records or selfreported 
(cohortspecific information in Supporting Information Table S2). Maternal BMI before pregnancy, 
available in 96% of the study population, was used in the analyses. For participants without 
information on prepregnancy BMI, BMI obtained before 20 weeks of gestation was used. 
Maternal BMI was categorised into underweight (<18.5 kg/m2), normal weight (18.5–24.9 kg/m2), 
overweight (25.0–29.9 kg/m2), obesity grade 1 (30.0–34.9 kg/m2), obesity grade 2 (35.0–
39.9 kg/m2), and obesity grade 3 (≥40.0 kg/m2),13 and into 11 groups with a range of 2.5 kg/m2 
each. Information on total gestational weight gain, defined as the difference between the latest 
weight before delivery and prepregnancy weight, was provided by the cohorts and was classified 
as inadequate, adequate or excessive weight gain in relation to maternal prepregnancy BMI 
according to the IOM guidelines.14 We calculated weight gain until 20 weeks of gestation as the 
difference between a weight obtained until median 15.4 weeks (95% CI 10.0–19.3) and 
prepregnancy weight. We calculated maternal prepregnancy BMIspecific weight gain for 
gestational age zscores based on reference charts created using data from this collaboration 
(Supporting Information Appendix S1).15 These zscores were categorised into six categories 
[<−2.0 standard deviation (SD), −2.0 to −1.1 SD, −1.0 to −0.1 SD, 0–0.9 SD, 1.0–1.9 SD and ≥2.0 
SD) and into low (≤−1.1 SD), medium (−1.0 to 0.9 SD) and high (≥1.0 SD) weight gain.  
Pregnancy complications 
Information on gestational hypertension, preeclampsia, gestational diabetes, gestational age at 
birth, and birthweight was measured, derived from clinical records or reported (cohortspecific 
information in Table S2). Preterm birth was defined as <37 weeks of gestation.16 We created sex 
and gestational ageadjusted birthweight SD scores based on a North European reference chart.17 
Small and large for gestational age at birth were defined per cohort as sex and gestational 
ageadjusted birth weight <10th percentile and >90th percentile, respectively. Any pregnancy 
complication was defined as at least one of the pregnancy complications. A core outcome set was 
not used in this study.  
Covariates 
Information on covariates was assessed by questionnaires and provided by the cohorts as 
categorical covariates: educational level (low, medium, high), parity (nulliparous, multiparous), 
smoking habits during pregnancy (yes, no), and child's sex. Maternal age was categorised based on 
data availability as <25.0, 25.0–29.9, 30.034.9, and ≥35.0 years. As part of the analysis plan, 
covariates were selected based on the graphical criteria for confounding and data availability in the 
cohorts.18 Maternal ethnicity was not included due to the fact that most cohorts were largely 
Caucasian and there was a high percentage of missings in ethnicspecific information. 
Cohortspecific information is given in Supporting Information Table S3.  
Statistical analysis 
We conducted onestage IPD metaanalysis by analysing individuallevel data from all cohorts 
simultaneously in a multilevel model. Our model followed a twolevel hierarchical structure with 
participants (level 1) nested within cohorts (level 2).19 We used generalised linear mixed models 
with a binomial distribution and logit link. We defined the models assuming a random intercept at 
cohort level to allow variation in the baseline risk for each cohort. We used these models to 
examine the separate and combined associations of maternal prepregnancy BMI and gestational 
weight gain, in clinical categories and across the full range, with the risks of pregnancy 
complications. We only examined the associations of gestational weight gain clinical categories 
with the risks of small and large for gestational age at birth due to the possibility of reverse 
causality for the other outcomes. The associations of excessive weight gain with gestational 
hypertensive disorders might be partly explained by pathological fluid retention as part of the 
disease. Women diagnosed with gestational diabetes might try to improve their diet and restrict 
their total weight gain. Preterm birth shortens the gestation and thus women are less likely to gain 
excessive gestational weight. The proportion of pregnancy complications at a population level 
attributable to each maternal prepregnancy BMI, and gestational weight gain clinical category 
was estimated by calculation of populationattributable risk fractions. For this, we used the 
adjusted odds ratio (OR) and the prevalence of the exposure category in the population.20 To study 
the effects of weight gain across the full range on gestational hypertension, preeclampsia, and 
gestational diabetes, we used weight gain zscores until 20 weeks of gestation to avoid reverse 
causality. For the models using maternal prepregnancy BMI and gestational weight gain zscores 
continuously, the inclusion of quadratic terms did not improve the fit. We did not observe statistical 
interactions between both maternal BMI and gestational weight gain with child's sex. All models 
were adjusted for maternal age, educational level, parity, and smoking habits during pregnancy. 
Models for birth complications were additionally adjusted for child's sex. Models for weight gain 
across the full range were also adjusted for maternal prepregnancy BMI. As sensitivity analyses, 
we conducted twostage IPD metaanalyses and tested for heterogeneity between the cohorts 
estimates.19, 21 We used missing values in covariates as an additional group to prevent exclusion 
of noncomplete cases. We performed statistical analyses using the Statistical Package of Social 
Sciences version 21.0 for Windows (SPSS Inc., Chicago, IL, USA) and Review Manager 
(REVMAN) version 5.3 of the Cochrane Collaboration (The Nordic Cochrane Centre, Copenhagen, 
Denmark).  
Results 
Participants’ characteristics 
Supporting Information Table S4 shows cohortspecific information on maternal anthropometrics 
and pregnancy complications. Overall, the median maternal pre/earlypregnancy BMI and total 
gestational weight gain were 22.7 kg/m2 (95% CI 18.1–34.7 kg/m2), and 14.0 kg (95% CI 3.9–
27.0 kg), respectively.  
Maternal prepregnancy BMI and risks of pregnancy complications 
Table 1 shows that, compared with normal weight mothers, underweight, overweight, and obesity 
grade 1–3 mothers had higher risks of any pregnancy complication (all Pvalues <0.05). The 
highest risk of any pregnancy complication was observed for obesity grade 3 mothers (OR 2.99, 
95% CI 2.68–3.34). Mothers with obesity grade 3 had also the highest risks of gestational 
hypertension (OR 5.40, 95% CI 4.47–6.51), preeclampsia (OR 6.50, 95% CI 5.48–7.73), 
gestational diabetes (OR 7.59, 95% CI 6.14–9.38), preterm birth (OR 1.52, 95% CI 1.24–1.87) and 
large for gestational age at birth (OR 3.06, 95% CI 2.69–3.49). We estimated that 23.9% of any 
pregnancy complication, specifically 35.6% of gestational hypertension, 34.6% of preeclampsia, 
42.8% of gestational diabetes, 3.9% of preterm birth, and 20.6% of large for gestational age at birth, 
were attributable to maternal overweight and obesity (Table 1).  
Table 1. Maternal prepregnancy BMI, and gestational weight gain clinical categories and the risks 
of pregnancy complicationsa 
 
Pregnancy complications Odds ratio (95% CI) and populationattributable risk 
fractions (PAR), % 
 Any 
pregnancy 
complicatio
n 
Gestational 
hypertensi
on 
Preeclam
psia 
Gestational 
diabetes 
Preterm 
birth 
Small size 
for 
gestational 
age 
Large size 
for 
gestational 
age 
Prepregnancy BMI  
1.08 (1.03, 
1.13)*  
0.63 (0.55, 
0.73)**  
0.67 (0.57, 
0.78)**  
0.66 (0.53, 
0.82)**  
1.20 (1.10, 
1.31)**  
1.67 (1.58, 
1.76)**  
0.45 (0.41, 
0.50)**  
PAR 2.3b  NA NA NA PAR 0.8 PAR 2.7 NA 
Under
weight 
(<18.5
 kg/m2
)  
ncases/total = 3
079/9586  
ncases/total = 2
16/9416  
ncases/total = 1
68/9368  
ncases/total = 8
5/10449  
ncases/total = 5
99/10455  
ncases/total = 1
900/10382  
ncases/total = 3
83/8865  
Reference Reference Reference Reference Reference Reference Reference Norma
l 
weight 
(18.5–
24.9 k
g/m2)  
ncases/total = 4
6774/15998
3  
ncases/total = 5
066/155612  
ncases/total = 4
100/154646 
ncases/total = 1
857/168117 
ncases/total = 7
852/172123 
ncases/total = 1
8185/15977
8  
ncases/total = 1
4674/15626
7  
Overw 1.35 (1.32, 2.04 (1.94, 1.96 (1.86, 2.22 (2.06, 1.06 (1.01, 0.79 (0.76, 1.61 (1.56, 
Pregnancy complications Odds ratio (95% CI) and populationattributable risk 
fractions (PAR), % 
 Any 
pregnancy 
complicatio
n 
Gestational 
hypertensi
on 
Preeclam
psia 
Gestational 
diabetes 
Preterm 
birth 
Small size 
for 
gestational 
age 
Large size 
for 
gestational 
age 
1.38)**  2.15)**  2.07)**  2.40)**  1.11)*  0.82)**  1.66)**  
PAR 11.4c  PAR 17.1 PAR 16.0 PAR 19.4 PAR 1.2 NA PAR 10.8 
eight 
(25.0–
29.9 k
g/m2)  
ncases/total = 1
6817/47825  
ncases/total = 2
531/45509  
ncases/total = 2
202/45180  
ncases/total = 1
156/49203  
ncases/total = 2
433/50852  
ncases/total = 4
074/44476  
ncases/total = 6
837/47239  
2.02 (1.96, 
2.08)**  
3.68 (3.46, 
3.91)**  
3.70 (3.48, 
3.93)**  
4.59 (4.22, 
4.99)**  
1.33 (1.25, 
1.41)**  
0.79 (0.75, 
0.83)**  
2.28 (2.19, 
2.37)**  
PAR 12.5c  PAR 18.5 PAR 18.6 PAR 23.4 PAR 2.7 NA PAR 9.8 
Obesit
y 
(≥30.0 
kg/m2)  ncases/total = 9
330/20834  
ncases/total = 1
687/18863  
ncases/total = 1
621/18797  
ncases/total = 1
020/21148  
ncases/total = 1
322/21992  
ncases/total = 1
694/18134  
ncases/total = 3
929/20369  
1.87 (1.80, 
1.93)**  
3.31 (3.08, 
3.55)**  
3.20 (2.98, 
3.44)**  
3.97 (3.61, 
4.37)**  
1.30 (1.21, 
1.39)**  
0.78 (0.73, 
0.83)**  
2.15 (2.05, 
2.25)**  
PAR 8.2c  PAR 12.5 PAR 12.0 PAR 15.5 PAR 1.8 NA PAR 6.6 
Obesit
y 
grade 
1 
(30.0–
34.9 k
g/m2)  
ncases/total = 6
505/15181  
ncases/total = 1
136/13900  
ncases/total = 1
047/13811  
ncases/total = 6
36/15405  
ncases/total = 9
36/16006  
ncases/total = 1
235/13363  
ncases/total = 2
725/14853  
2.36 (2.21, 
2.51)**  
4.66 (4.17, 
5.20)**  
4.81 (4.31, 
5.37)**  
5.85 (5.09, 
6.73)**  
1.38 (1.22, 
1.57)**  
0.79 (0.71, 
0.89)**  
2.56 (2.37, 
2.77)**  
PAR 3.7c  PAR 6.1 PAR 6.3 PAR 7.9 PAR 0.7 NA PAR 2.7 
Obesit
y 
grade 
2 
(35.0–
39.9 k
g/m2)  
ncases/total = 2
091/4308  
ncases/total = 4
12/3812  
ncases/total = 4
10/3810  
ncases/total = 2
71/4386  
ncases/total = 2
87/4557  
ncases/total = 3
45/3662  
ncases/total = 8
88/4205  
2.99 (2.68, 
3.34)**  
5.40 (4.47, 
6.51)**  
6.50 (5.48, 
7.73)**  
7.59 (6.14, 
9.38)**  
1.52 (1.24, 
1.87)**  
0.86 (0.70, 
1.04) 
3.06 (2.69, 
3.49)**  
PAR 1.7c  PAR 2.4 PAR 2.9 PAR 3.5 PAR 0.3 NA PAR 1.1 
Obesit
y 
grade 
3 
(≥40.0 
kg/m2)  
ncases/total = 7
34/1345  
ncases/total = 1
39/1151  
ncases/total = 1
64/1176  
ncases/total = 1
13/1357  
ncases/total = 9
9/1429  
ncases/total = 1
14/1109  
ncases/total = 3
16/1311  
Gestational weight gain  
     1.57 (1.51, 1.63)**  
0.65 (0.62, 
0.68)**  
     PAR 11.0 NA 
Inadeq
uate 
weight 
gain      ncases/total = 6512/40322  
ncases/total = 2
150/35960  
     Reference Reference Adequ
ate 
weight 
gain 
     ncases/total = 7406/66330  
ncases/total = 5
592/64516  
Excess
ive      
0.62 (0.60, 
0.65)**  
2.11 (2.04, 
2.18)**  
Pregnancy complications Odds ratio (95% CI) and populationattributable risk 
fractions (PAR), % 
 Any 
pregnancy 
complicatio
n 
Gestational 
hypertensi
on 
Preeclam
psia 
Gestational 
diabetes 
Preterm 
birth 
Small size 
for 
gestational 
age 
Large size 
for 
gestational 
age 
     NA PAR 31.6 weight 
gain 
     ncases/total = 5632/70709  
ncases/total = 1
1994/77071 
• PAR is the populationattributable risk fraction in percentage that reflects the proportion of 
pregnancy complications at a populationlevel attributable to each maternal prepregnancy 
BMI and gestational weight gain clinical category.  
• NA, not applicable.  
• ncases/total represent the number of cases for each pregnancy complication in each clinical 
category/the population in each clinical category. Values are odds ratios (95% confidence 
intervals) from multilevel binary logistic regression models that reflect the risk of pregnancy 
complications per prepregnancy BMI and gestational weight gain clinical category 
compared with the reference group (normal weight and adequate weight gain). Mothers 
diagnosed with preeclampsia were excluded from the models for gestational hypertension. 
The reference group for the analyses on preeclampsia comprises the mothers without both 
preeclampsia and gestational hypertension. The reference group for the analyses on small 
and large for gestational age at birth is appropriate size for gestational age at birth. Models 
are adjusted for maternal age, educational level, parity, and smoking habits during 
pregnancy. Models for birth complications are additionally adjusted for child's sex.  
• PAR calculated based on preterm birth and small for gestational age at birth.  
• PAR calculated based on gestational hypertension, preeclampsia, gestational diabetes, 
preterm birth, and large for gestational age at birth.  
• *P < 0.05; **P < 0.001.  
Figure 1 shows that higher maternal prepregnancy BMI was associated across the full range with 
higher risks of gestational hypertensive disorders, gestational diabetes, and large for gestational age 
at birth and with a lower risk of small for gestational age at birth (P < 0.05). Both lower and higher 
maternal prepregnancy BMI were associated with a higher risk of preterm birth (P < 0.05). 
Similar results were observed in the unadjusted models (Supporting Information Table S5 and 
Fig. S2). The risks of pregnancy complications per kg/m2 are given in the footnotes of Figures 1 and 
S2. Similar results were observed in twostage IPD metaanalysis (Supporting Information 
Figure S3).  
Maternal prepregnancy body mass index and the risks of pregnancy complicationsa. aValues are 
odds ratios, 95% confidence intervals) on a log scale from multilevel binary logistic regression 
models that reflect the risk of pregnancy complications per prepregnancy BMI group compared 
with the reference group (largest group, 20.0–22.4 kg/m2). The bars represent the percentage of 
each pregnancy complication per BMI group. Mothers diagnosed with preeclampsia were 
excluded from the models for gestational hypertension. The reference group for the analyses on 
preeclampsia comprises the mothers without both preeclampsia and gestational hypertension. 
The reference group for the analyses on small and large for gestational age at birth is appropriate 
size for gestational age at birth. Models are adjusted for maternal age, educational level, parity, and 
smoking habits during pregnancy. Models for birth complications are additionally adjusted for 
child's sex. The EXCEL trendline function was used to fit the curve to the data. The risks of 
pregnancy complications per kg/m2 were: gestational hypertension (OR 1.11, 95% CI 1.11–1.12), 
preeclampsia (OR 1.11, 95% CI 1.11–1.12), gestational diabetes (OR 1.12, 95% CI 1.12–1.13), 
preterm birth (OR 1.02, 95% CI 1.01–1.02), small size for gestational age at birth (OR 0.96, 95% 
CI 0.95–0.96), and large for gestational age at birth (OR 1.08, 95% CI 1.08–1.08).  
Gestational weight gain and risks of pregnancy complications 
Table 1 shows that, compared with mothers with adequate gestational weight gain, mothers with 
excessive gestational weight gain had a lower risk of small for gestational age at birth (OR 0.62, 
95% CI 0.60–0.65) and a higher risk of large for gestational age at birth (OR 2.11, 95% CI 2.04–
2.18). We estimated that 11.0% of small for gestational age at birth and 31.6% of large for 
gestational age at birth were attributable to inadequate and excessive gestational weight gain, 
respectively.  
Figure 2 shows that higher weight gain zscores until 20 weeks of gestation were associated with 
higher risks of gestational hypertension, preeclampsia, and gestational diabetes. Both lower and 
higher total gestational weight gain zscores were associated with a higher risk of preterm birth 
(P < 0.05). Higher total gestational weight gain zscores were, across the full range, associated 
with a lower risk of small for gestational age at birth and a higher risk of large for gestational age at 
birth (P < 0.05). Similar results were observed in the unadjusted models (Supporting Information 
Table S5 and Figure S4). The risks of pregnancy complications per SD increase in gestational 
weight gain are given in the footnotes of Figures 2 and S4. Similar results were observed in 
twostage IPD metaanalysis (Figure S5).  
Gestational weight gain and the risks of pregnancy complicationsa. aValues are odds ratios, 95% 
confidence intervals) on a log scale from multilevel binary logistic regression models that reflect the 
risk of pregnancy complications per gestational weight gain group compared with the reference 
group (largest group, –1.0 to –0.1 SD). The bars represent the percentage of each pregnancy 
complication per gestational weight gain group. Mothers diagnosed with preeclampsia were 
excluded from the models for gestational hypertension. The reference group for the analyses on 
preeclampsia comprises the mothers without both preeclampsia and gestational hypertension. 
The reference group for the analyses on small and large for gestational age at birth is appropriate 
size for gestational age at birth. Models are adjusted for maternal age, educational level, parity, 
smoking habits during pregnancy, and maternal prepregnancy BMI. Models for birth 
complications are additionally adjusted for child's sex. The EXCEL trendline function was used to 
fit the curve to the data. The risks of pregnancy complications per SD increase in gestational weight 
gain were: gestational hypertension (OR 1.12, 95% CI 1.09–1.14), preeclampsia (OR 1.07, 95% 
CI 1.05–1.10), gestational diabetes (OR 1.14, 95% CI 1.10–1.18), preterm birth (OR 1.09, 95% CI 
1.07–1.11), small for gestational age at birth (OR 0.73, 95% CI 0.72–0.74), and large for gestational 
age at birth (OR 1.53, 95% CI 1.51–1.55).  
Maternal prepregnancy BMI and gestational weight gain, and risks of pregnancy 
complications 
Table 2 shows that, compared with normal weight mothers with medium gestational weight gain, 
overweight and obese mothers had higher risks of any pregnancy complication, independent of their 
gestational weight gain (P < 0.05). The highest risk of any pregnancy complication was observed 
for obese mothers with high weight gain (OR 2.51, 95% CI 2.31–2.74). Low and high gestational 
weight gain were also, among normal weight mothers, associated with a higher risk of any 
pregnancy complication (P < 0.05). Obese mothers with high gestational weight gain had the 
highest risks of gestational hypertension (OR 4.52, 95% CI 3.86–5.31), preeclampsia (OR 4.58, 
95% CI 3.90–5.37), gestational diabetes (OR 7.84, 95% CI 6.38–9.62), preterm birth (OR 2.14, 
95% CI 1.86–2.46), and large for gestational age at birth (OR 4.77, 95% CI 4.35–5.22). 
Underweight mothers with low gestational weight gain had the highest risk of small for gestational 
age at birth (OR 3.12, 95% CI 2.75–3.54). Similar results were observed in the unadjusted models 
(Supporting Information Table S6).  
Table 2. Maternal prepregnancy BMI and gestational weight gain categories, and the risks of 
pregnancy complicationsa 
Pregnancy complications Odds ratio (95% CI) 
 Any 
pregnancy 
complication 
Gestational 
hypertensio
n 
Preeclam
psia 
Gestational 
diabetes 
Preterm 
birth 
Small size 
for 
gestational 
age 
Large size 
for 
gestational 
age 
Underweight  
1.09 (0.94, 
1.26) 
0.56 (0.39, 
0.79)*  
0.45 (0.26, 
0.78)*  
1.39 (0.77, 
2.49) 
1.82 (1.47, 
2.27)**  
3.12 (2.75, 
3.54)**  
0.23 (0.15, 
0.35)**  
Low 
wei
ght 
gain 
(≤−
1.1 
SD) 
ncases/total = 31
0/960  
ncases/total = 3
3/1002  
ncases/total = 1
3/982  
ncases/total = 1
2/1077  
ncases/total = 9
2/1304  
ncases/total = 3
60/1332  
ncases/total = 2
1/993  
1.04 (0.96, 
1.12) 
0.65 (0.51, 
0.81)**  
0.68 (0.53, 
0.86)*  
0.55 (0.34, 
0.90)*  
1.24 (1.08, 
1.42)*  
1.76 (1.63, 
1.90)**  
0.45 (0.38, 
0.53)**  
Med
ium 
wei
ght 
gain 
(−1.
0 to 
0.9 
SD) 
ncases/total = 11
39/4022  
ncases/total = 8
1/3999  
ncases/total = 6
8/3986  
ncases/total = 1
7/4302  
ncases/total = 2
31/4890  
ncases/total = 8
89/4916  
ncases/total = 1
64/4191  
1.13 (0.98, 
1.30) 
1.07 (0.76, 
1.50) 
1.22 (0.82, 
1.79) 
0.56 (0.23, 
1.36) 
1.23 (0.97, 
1.57) 
0.79 (0.67, 
0.95)*  
0.98 (0.79, 
1.22) 
Hig
h 
wei
ght 
gain 
(≥1.
0 
SD) 
ncases/total = 33
0/1021  
ncases/total = 3
7/974  
ncases/total = 2
7/964  
ncases/total = 5
/1152  
ncases/total = 7
2/1396  
ncases/total = 1
45/1324  
ncases/total = 8
8/1267  
Normal weight  
1.04 (1.01, 
1.08)*  
0.98 (0.90, 
1.07) 
1.02 (0.92, 
1.13) 
0.90 (0.73, 
1.09) 
1.17 (1.09, 
1.26)**  
1.81 (1.73, 
1.89)**  
0.52 (0.49, 
0.56)**  
Low 
wei
ght 
gain 
(≤−
1.1 
SD) 
ncases/total = 57
02/19877  
ncases/total = 8
53/19649  
ncases/total = 5
39/19335  
ncases/total = 1
36/20792  
ncases/total = 9
46/21290  
ncases/total = 3
647/20991  
ncases/total = 8
85/18229  
Reference Reference Reference Reference Reference Reference Reference Med
ium 
wei
ncases/total = 17
957/68457  
ncases/total = 1
918/66938  
ncases/total = 1
606/66626  
ncases/total = 4
97/70805  
ncases/total = 3
196/84958  
ncases/total = 8
584/79555  
ncases/total = 6
592/77563  
Pregnancy complications Odds ratio (95% CI) 
 Any 
pregnancy 
complication 
Gestational 
hypertensio
n 
Preeclam
psia 
Gestational 
diabetes 
Preterm 
birth 
Small size 
for 
gestational 
age 
Large size 
for 
gestational 
age 
ght 
gain 
(−1.
0 to 
0.9 
SD) 
1.10 (1.06, 
1.14)**  
1.39 (1.28, 
1.52)**  
1.24 (1.12, 
1.37)**  
1.34 (1.14, 
1.58)**  
1.34 (1.25, 
1.43)**  
0.57 (0.54, 
0.61)**  
2.26 (2.17, 
2.37)**  
Hig
h 
wei
ght 
gain 
(≥1.
0 
SD) 
ncases/total = 59
10/20051  
ncases/total = 8
17/19247  
ncases/total = 5
30/18960  
ncases/total = 2
18/20991  
ncases/total = 1
321/25135  
ncases/total = 1
607/21532  
ncases/total = 3
674/23599  
Overweight  
1.23 (1.16, 
1.32)**  
1.46 (1.25, 
1.71)**  
1.86 (1.61, 
2.15)**  
1.91 (1.46, 
2.50)**  
1.15 (1.01, 
1.30)*  
1.23 (1.14, 
1.33)**  
0.92 (0.84, 
1.01) 
Low 
wei
ght 
gain 
(≤−
1.1 
SD) 
ncases/total = 15
41/5219  
ncases/total = 1
85/5024  
ncases/total = 2
17/5056  
ncases/total = 6
2/5333  
ncases/total = 2
78/6510  
ncases/total = 7
59/6117  
ncases/total = 4
96/5854  
1.38 (1.33, 
1.43)**  
2.10 (1.94, 
2.27)**  
2.10 (1.93, 
2.28)**  
2.40 (2.09, 
2.75)**  
1.07 (1.00, 
1.15) 
0.77 (0.73, 
0.81)**  
1.77 (1.69, 
1.85)**  
Med
ium 
wei
ght 
gain 
(−1.
0 to 
0.9 
SD) 
ncases/total = 70
96/21817  
ncases/total = 1
118/20804  
ncases/total = 9
86/20672  
ncases/total = 3
68/22326  
ncases/total = 1
025/25596  
ncases/total = 1
930/22445  
ncases/total = 3
390/23905  
1.63 (1.54, 
1.73)**  
2.71 (2.41, 
3.06)**  
2.54 (2.23, 
2.90)**  
3.49 (2.89, 
4.22)**  
1.49 (1.34, 
1.66)**  
0.51 (0.46, 
0.57)**  
3.46 (3.24, 
3.69)**  
Hig
h 
wei
ght 
gain 
(≥1.
0 
SD) 
ncases/total = 20
89/5613  
ncases/total = 3
61/5237  
ncases/total = 2
82/5158  
ncases/total = 1
53/5767  
ncases/total = 3
95/6911  
ncases/total = 3
68/5460  
ncases/total = 1
423/6515  
Obesity  
1.70 (1.56, 
1.85)**  
3.06 (2.57, 
3.66)**  
3.52 (3.00, 
4.14)**  
4.44 (3.41, 
5.77)**  
1.36 (1.15, 
1.62)**  
0.99 (0.87, 
1.12) 
1.45 (1.29, 
1.63)**  
Low 
wei
ght 
gain 
ncases/total = 91
6/2534  
ncases/total = 1
48/2344  
ncases/total = 1
82/2378  
ncases/total = 6
8/2577  
ncases/total = 1
48/2957  
ncases/total = 2
79/2639  
ncases/total = 3
37/2697  
Pregnancy complications Odds ratio (95% CI) 
 Any 
pregnancy 
complication 
Gestational 
hypertensio
n 
Preeclam
psia 
Gestational 
diabetes 
Preterm 
birth 
Small size 
for 
gestational 
age 
Large size 
for 
gestational 
age 
(≤−
1.1 
SD) 
2.06 (1.96, 
2.16)**  
3.88 (3.53, 
4.26)**  
4.01 (3.64, 
4.40)**  
5.09 (4.40, 
5.89)**  
1.32 (1.20, 
1.46)**  
0.80 (0.74, 
0.86)**  
2.57 (2.43, 
2.72)**  
Med
ium 
wei
ght 
gain 
(−1.
0 to 
0.9 
SD) 
ncases/total = 38
18/9080  
ncases/total = 7
24/8208  
ncases/total = 6
95/8179  
ncases/total = 3
44/9220  
ncases/total = 5
34/10807  
ncases/total = 8
10/8924  
ncases/total = 1
928/10042  
2.51 (2.31, 
2.74)**  
4.52 (3.86, 
5.31)**  
4.58 (3.90, 
5.37)**  
7.84 (6.38, 
9.62)**  
2.14 (1.86, 
2.46)**  
0.60 (0.51, 
0.70)**  
4.77 (4.35, 
5.22)**  
Hig
h 
wei
ght 
gain 
(≥1.
0 
SD) 
ncases/total = 10
98/2323  
ncases/total = 2
02/2074  
ncases/total = 1
94/2066  
ncases/total = 1
34/2374  
ncases/total = 2
30/2820  
ncases/total = 1
65/2085  
ncases/total = 7
32/2652  
• a ncases/total represents the number of cases for each pregnancy complication in each group/the 
population in each group. Values are odds ratios (95% CI) from multilevel binary logistic 
regression models that reflect the risk of pregnancy complications per combined 
prepregnancy BMI and gestational weight gain categories compared with the reference 
group (normal weight and medium weight gain). For any pregnancy complication, 
gestational hypertension, preeclampsia, and gestational diabetes, weight gain zscores 
until 20 weeks of gestation were used; for preterm birth, and small and large for gestational 
age at birth, total gestational weight gain zscores were used. Mothers diagnosed with 
preeclampsia were excluded from the models for gestational hypertension. The reference 
group for the analyses on preeclampsia comprises the mothers without both 
preeclampsia and gestational hypertension. The reference group for the analyses on small 
and large for gestational age at birth is appropriate size for gestational age at birth. Models 
are adjusted for maternal age, educational level, parity, and smoking habits during 
pregnancy. Models for birth complications are additionally adjusted for child's sex.  
• *P < 0.05; **P < 0.001. Significant interaction terms were present (P < 0.05) for preterm 
birth, and small and large for gestational age at birth.  
Discussion 
Main findings 
In this IPD metaanalysis, higher maternal prepregnancy BMI and gestational weight gain were, 
across the full range, associated with higher risks of gestational hypertensive disorders, gestational 
diabetes, and large for gestational age at birth. Preterm birth risk was higher at both BMI and 
weight gain extremes. Obese mothers with high gestational weight gain had the highest risk of any 
pregnancy complication. We estimated that up to 24% of any pregnancy complication could be 
attributed to maternal overweight and obesity, whereas up to 32% of large for gestational age 
infants could be attributed to excessive gestational weight gain. However, the estimated 
populationattributable risks should be carefully interpreted, as the causality of the observed 
associations remains unknown. 
Strengths and limitations 
We performed a large metaanalysis of IPD from many cohorts. As part of an international 
collaboration between pregnancy and birth cohort studies, we invited all cohorts from Europe, 
North America, and Oceania that we were able to identify from existing large international 
collaborations on childhood health and that met the inclusion criteria. Therefore, we believe this 
metaanalysis covers a large proportion of individual participant data available on this topic. 
However, we cannot disregard the possibility of data missing from other cohorts, especially recent 
cohorts, that were not included. We did not rely on published data, limiting any potential 
publication bias and enabling a consistent definition of exposures, confounders, and outcomes. The 
large sample size enabled us to study the risks of pregnancy complications in relatively rare 
conditions, such as severe obesity. We did not consider additional levels, such as country and 
continent, in our multilevel modelling due to the high computational complexity required for this 
approach, and the likely minimal influence of this on the findings. We performed twostage 
metaanalyses as sensitivity analyses, which gave similar results and showed moderatetohigh 
heterogeneity between the cohorts estimates. Missing values of covariates were used as an 
additional group. This approach, although commonly used in large IPD metaanalyses due to the 
constraints in applying more advanced imputation strategies, might lead to bias.22 However, in the 
current study, bias is unlikely, considering the small percentage of missings and the similar findings 
between unadjusted and adjusted models. We relied on weights obtained partly by selfreport, 
which might be a source of error. However, a large systematic review showed that reporting error 
did not bias associations between pregnancyrelated weight and birth outcomes.23 We used 
maternal prepregnancy BMIspecific weight gain for gestational age zscores, which classify 
weight gain independently of gestational age.15 This approach allows assessment of the unbiased 
associations between gestational weight gain and pregnancy outcomes that are highly correlated 
with gestational age at birth. This method is needed because the absolute value related to the 
zscore changes across pregnancy. However, the use of zscores might complicate the clinical 
interpretation of the observed associations. Some cohorts relied on selfreporting to obtain 
information on gestational hypertensive and diabetic disorders. If misclassification of women 
occurred, our associations might be attenuated. As in any observational study, residual confounding 
by unmeasured lifestylerelated variables may be an issue.  
Interpretation 
Maternal obesity is a major public health concern.24 A metaanalysis of published cohort studies 
showed that maternal obesity is associated with a higher risk of fetal and infant death.2 Maternal 
obesity is also associated with increased risks of more common pregnancy complications, such as 
gestational hypertensive disorders, gestational diabetes, preterm birth, and large for gestational age 
at birth,3-5 which are important risk factors for both maternal and neonatal morbidity and 
mortality.25-28 In line with these previous studies, we observed that maternal prepregnancy 
overweight and obesity are related to increased risks for any of these pregnancy complications. 
Mothers with obesity grade 3 showed the highest risks. Importantly, we estimated that over 40% of 
gestational hypertensive and diabetic disorders could be attributed to maternal overweight and 
obesity. Smaller but yet considerable risk fractions attributable to maternal overweight/obesity were 
observed for preterm birth (3.9%) and large for gestational age at birth (20.6%). Overall, 23.9% of 
any pregnancy complication was estimated to be attributable to maternal prepregnancy 
overweight/obesity, which underlines their major public health implications and the possibility to 
substantially reduce pregnancy complications by optimising maternal BMI.  
The associations of maternal BMI with pregnancy complications were also present across the full 
range. Even modest increases of maternal prepregnancy BMI were associated with higher risks of 
gestational hypertensive disorders, gestational diabetes, and large for gestational age at birth. The 
association of maternal prepregnancy BMI with the risk of preterm birth tended to be Ushaped. 
Thus, our findings suggest that mothers do not necessarily need to become overweight or obese to 
be at risk of pregnancy complications, as higher risks of pregnancy complications were already 
observed for an increase in BMI within the healthy range.  
Next to prepregnancy BMI, excessive gestational weight gain may affect the risks of pregnancy 
complications.6-9 We observed gradually higher risks of gestational hypertension, preeclampsia, 
and gestational diabetes over the full range of weight gain. Similar to the association of maternal 
BMI, the association of total gestational weight gain zscores with preterm birth tended to be 
Ushaped. We also observed that not only excessive weight gain but also higher weight gain across 
the full range was associated with a higher risk of large for gestational age at birth. At the 
population level, 31.6% of large for gestational age infants could be attributed to excessive weight 
gain. Altogether, these findings suggest that gradual increases in gestational weight gain, and not 
only excessive weight gain, are associated with higher risks of pregnancy complications.  
We also assessed the combined effects of prepregnancy BMI and gestational weight gain on 
pregnancy complications. Previous studies have shown that mothers with both high BMI and 
gestational weight gain had the highest risk of having large for gestational age children. The risk of 
preterm birth was increased at both extremes.29-33 In line with these previous studies, we observed 
that obese mothers with high weight gain were at the highest risk of any pregnancy complication. 
Importantly, we also observed that overweight and obese mothers are at risk of these complications, 
regardless how much weight they gain during pregnancy. These findings show the importance of 
promoting a healthy weight status before and during pregnancy.  
The mechanisms underlying the associations of maternal adiposity and pregnancy complications are 
not fully understood yet, but may include insulin resistance, endothelial dysfunction, oxidative 
stress, lipotoxicity, inflammation, and infection.3, 4, 34 The associations of maternal adiposity with 
large for gestational age infants might be explained by fetal overnutrition, as an increased 
placental transfer of nutrients to the fetus might lead to an increased synthesis of insulin and 
insulinlike growth factors, both of which are growthpromoting hormones.35 The causal role of 
glucose is also suggested in a large Mendelian randomisation study.36 Gestational weight gain 
reflects fat storage during pregnancy, but also reflects fetus growth, amniotic fluid, placenta, uterine 
and mammary tissue expansion, increased blood volume, and extracellular fluid.37 These factors 
may all have different roles in the associations with pregnancy complications. From the current 
observational data, we cannot derive conclusions about the mechanisms underlying the observed 
associations.  
We observed that a high percentage of pregnancy complications are attributable to suboptimal 
maternal BMI and gestational weight gain, which suggests the potential for prevention of pregnancy 
complications by optimising these maternal measures. Thus far, randomised trials focused on 
lifestyle interventions to improve gestational weight gain and subsequent pregnancy complications 
are disappointing. An IPD metaanalysis from randomised trials focused on lifestyle interventions 
in pregnancy, showed a reduction in gestational weight gain but no effects on gestational 
hypertensive and diabetic disorders, preterm birth or size for gestational age.38 Strategies to 
improve BMI before pregnancy rather than during pregnancy may be more effective in the 
prevention of pregnancy complications.  
Conclusion 
Maternal prepregnancy BMI and gestational weight gain are, across the full range, associated with 
the risks of pregnancy complications. Obese mothers with high gestational weight gain are at the 
highest risk of pregnancy complications. Up to 30% of any pregnancy complication is estimated to 
be attributable to overweight/obesity or excessive gestational weight gain. Our findings provide 
evidence for advocating a healthy BMI in women who are planning to become pregnant and an 
adequate weight gain during pregnancy to reduce the burden of obstetric and neonatal morbidity. 
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